President Volodymyr Zelenskyy heard a report from the military command of Ukraine. It concerned the situation at the front, according to Zelenskyy’s Telegram channel. According to Zelenskyy, the report was attended by Defense Minister Rustem Umerov, Co…
Zelenskyy hears updates from Commander-in-Chief and Defense Minister as preparations for Ramstein continue
President Volodymyr Zelenskyy heard a report from the military command of Ukraine. It concerned the situation at the front, according to Zelenskyy’s Telegram channel. According to Zelenskyy, the report was attended by Defense Minister Rustem Umerov, Co…
Simeone: “No voy a cambiar absolutamente nada de lo que dije, tergiversaron mi opinión”
El entrenador del Atlético de Madrid, Diego Pablo Simeone, ha asegurado que no cambia “absolutamente nada” de lo que dijo tras el derbi madrileño, cuando afirmó que Thibaut Courtois había provocado a la grada, y cree que se “tergiversaron” sus palabras…
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like Duchenne muscular dystrophy (DMD). Capricor’s stock surged more than 100% after announcing it will pursue f…
iPhones Always Display The Time As 9:41 During Apple Product Launches — The Tradition Dates Back To Steve Jobs
Apple Inc (NASDAQ:AAPL) unveiled its latest innovations at its “Glowtime” event last month. The company meticulously plans every detail of its presentations all the way down to the time displayed on its devices, which never changes. What To Know: Apple…
Microsoft abandons HoloLens 2 in a final break from mixed reality
Microsoft has discontinued production of the HoloLens 2, apparently ending its love affair with its augmented-reality headset and perhaps the metaverse in general. UploadVR cited a Microsoft representative who told the outlet that Microsoft has stopped…
Commonly used drug could revolutionize treatment of rare muscle disorder
This latest research on non-dystrophic myotonia offers promising results for those affected by the condition. Published in Lancet Neurology00320-X/fulltext), the study details a “head-to-head” trial comparing two drugs—mexiletine and lamotrigine—to fin…
Commonly used drug could revolutionize treatment of rare muscle disorder
This latest research on non-dystrophic myotonia offers promising results for those affected by the condition. Published in Lancet Neurology00320-X/fulltext), the study details a “head-to-head” trial comparing two drugs—mexiletine and lamotrigine—to fin…
Israel strikes into Hezbollah hideouts in Lebanon, asks civilians to evacuate
Jerusalem [Israel], October 1 (ANI): The Israeli military on Tuesday, issued a warning to 20 towns in southern Lebanon to evacuate immediately, as it aims to start limited ground operations against the Hezbollah terror group in Lebanon, as reported by …
Patent filings help scientists predict patterns in wildlife trade
By Abhishyant Kidangoor Economists have long made the case that regulations foster greater innovation by business players. This apparently also applies to businesses involved in the wildlife trade, new research suggests. In their recently published stu…